Chugai Pharmaceutical Co., Ltd. (CHGCF)
OTCMKTS · Delayed Price · Currency is USD
61.80
+2.86 (4.85%)
At close: Mar 10, 2026
Chugai Pharmaceutical Market Cap
Chugai Pharmaceutical has a market cap or net worth of $99.37 billion as of March 10, 2026. Its market cap has increased by 34.00% in one year.
Market Cap
99.37B
Enterprise Value
93.16B
Revenue
8.02B
Ranking
n/a
PE Ratio
35.90
Stock Price
$61.80
Market Cap Chart
Since January 6, 1992, Chugai Pharmaceutical's market cap has increased from 2.50B to 99.37B, an increase of 3,873.54%. That is a compound annual growth rate of 11.37%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 10, 2026 | 99.37B | 14.48% |
| Dec 30, 2025 | 86.81B | 18.46% |
| Dec 30, 2024 | 73.28B | 17.53% |
| Dec 29, 2023 | 62.35B | 48.41% |
| Dec 30, 2022 | 42.01B | -21.23% |
| Dec 30, 2021 | 53.34B | -39.09% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nika Pharmaceuticals | 791.42M |
| Veradigm | 724.25M |
| Glass House Brands | 718.57M |
| Elite Pharmaceuticals | 429.68M |
| Northwest Biotherapeutics | 367.72M |
| American Oncology Network | 360.64M |
| Silence Therapeutics | 294.27M |
| CytoDyn | 290.91M |